Showing results for Neurology
-
Beyond the lab: Community liaisons contribute to breakthroughs in Alzheimer’s research at IU
As a community research liaison for the Department of Neurology, Zipporah Melton was determined to break down the multifaceted barriers that often prevent underrepresented communities ...
Allie Northcutt | Nov 03, 2025 -
Falling back: Health tips to adjust to the time change
As the seasons begin to change and the winter months approach, this also means that daylight saving time is ending.
Jasmin Cheairs | Oct 21, 2025 -
IU neurodegenerative disorders expert shares her journey toward developing better Alzheimer’s treatments
As director of the IU Center for Neurodegenerative Disorders, Donna Wilcock leads one of the nation’s largest treatment and clinical trial sites for Alzheimer’s disease. ...
Laura Gates | Sep 02, 2025 -
Cerebrovascular expert brings background in stroke and Alzheimer’s disease research to the IU School of Medicine
Candice Brown joined the IU School of Medicine to grow the school’s neurovascular basic science and clinical research programs.
Ben Middelkamp | Aug 14, 2025 -
Neuroscience experts collaborate to advance minimally invasive procedure to treat movement disorders
Stereotactic and functional neurosurgery specialists in the Department of Neurological Surgery and movement disorder specialists in the Department of Neurology have been performing the deep ...
Allie Northcutt | Jul 31, 2025 -
Two IU leaders in Alzheimer's disease research receive international acclaim
IU Alzheimer's disease researchers Bruce Lamb and Donna Wilcock received prestigious awards at the Alzheimer’s Association International Conference, recognizing them as leaders and mentors in ...
Laura Gates | Jul 29, 2025 -
AI in Medicine: What is your 'aha' moment?
This column is the third in a four-part series from Taeho Jo, titled "AI in Medicine: From Nobel Discoveries to Clinical Frontiers."
Taeho Jo | Jul 11, 2025 -
IU neurologist's research leads to first FDA-approved drug to treat neurofibromatosis type 1
Patients who participated in the clinical trial of the new therapy not only experienced reduction in NF1 and plexiform neurofibromas tumor volume, but also reported ...
Allie Northcutt | Jun 10, 2025 -
ALS researcher aims to discover hidden causes of neuromuscular disease on quest for new therapies
ALS Awareness Month: Brian Pierchala, PhD, is growing ALS research at IU School of Medicine through the Motoneuron Club and collaborative science.
Laura Gates | May 02, 2025 -
Brain health program fuels clinical and research advancements of new Alzheimer’s disease treatments in Indiana
Indiana patients are among the first people in the country to receive new disease-modifying drugs for Alzheimer's disease, contributing to the work of IU School ...
Ben Middelkamp | Apr 24, 2025